Nemaura Medical Inc. (NMRD) Financial Statements (2026 and earlier)

Company Profile

Business Address 57 WEST 57TH STREET
MANHATTAN, NY 10019
State of Incorp.
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

12/31/2023
Q3
9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,3784,01010,1057,34110,11014,752
Cash and cash equivalent1,3784,01010,1057,34110,11014,752
Receivables28625441025 218
Inventory, net of allowances, customer advances and progress billings2,9112,3511,7552,3521,9101,625
Inventory2,9112,3511,7552,3521,9101,625
Advance royalties   1,000   
Other undisclosed current assets3,4878582681,2171,9341,105
Total current assets:8,0627,47313,53710,93613,95417,700
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization582629642   
Intangible asset, including goodwill, after accumulated amortization274348384   
Intangible asset, excluding goodwill, after accumulated amortization274348384   
Other noncurrent assets    2,0261,9492,015
Total noncurrent assets:8569771,0262,0261,9492,015
TOTAL ASSETS:8,9198,45014,56312,96215,90319,715
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities41925732717130193
Accounts payable41925732717130193
Deferred revenue1,1291271247071178
Debt17,55116,96816,94311,51317,19715,870
Other liabilities    391398438
Due to related parties✕✕✕✕ 122 
Other undisclosed current liabilities2,3294,3034,8751,0762,0661,280
Total current liabilities:21,42821,65422,26813,22020,15517,858
Noncurrent Liabilities
Long-term debt and lease obligation 3,3601193,0888,5583,4914,700
Long-term debt, excluding current maturities 3,3601193,0888,5583,4914,700
Other undisclosed noncurrent liabilities  1,0541,0221,0439561,025
Total noncurrent liabilities: 3,3601,1734,1099,6004,4475,725
Total liabilities:24,78922,82826,37722,82024,60223,583
Equity
Equity, attributable to parent(15,870)(14,378)(11,814)(9,859)(8,699)(3,868)
Common stock292929242424
Additional paid in capital40,99140,99140,99138,29638,29638,296
Accumulated other comprehensive loss(1,208)(920)(959)(987)(1,543)(567)
Accumulated deficit(55,682)(54,478)(51,875)(47,192)(45,476)(41,620)
Total equity:(15,870)(14,378)(11,814)(9,859)(8,699)(3,868)
TOTAL LIABILITIES AND EQUITY:8,9198,45014,56312,96215,90319,715

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

12/31/2023
Q3
9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
Revenues    374 
Cost of revenue
(Cost of Product and Service Sold)		   (0)(3)(72) 
Other undisclosed gross profit   (1,478)   
Gross profit:   (1,478)02 
Operating expenses(2,051)(2,058)(2,809)(633)(2,240)(2,437)
Other undisclosed operating income  224    
Operating loss:(2,051)(1,834)(4,287)(633)(2,238)(2,437)
Loss from continuing operations before equity method investments, income taxes:(2,051)(1,834)(4,287)(633)(2,238)(2,437)
Other undisclosed loss from continuing operations before income taxes   (4,549)   
Loss from continuing operations before income taxes:(2,051)(1,834)(8,835)(633)(2,238)(2,437)
Other undisclosed income from continuing operations   38   
Loss from continuing operations:(2,051)(1,834)(8,798)(633)(2,238)(2,437)
Other undisclosed net loss  (769)(38) (1,617) 
Net loss:(2,051)(2,603)(8,835)(633)(3,856)(2,437)
Other undisclosed net income (loss) attributable to parent847 4,152(1,083) (1,452)
Net loss available to common stockholders, diluted:(1,203)(2,603)(4,683)(1,716)(3,856)(3,889)

Comprehensive Income ($ in thousands)
Annual | Quarterly

12/31/2023
Q3
9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
Net loss:(2,051)(2,603)(8,835)(633)(3,856)(2,437)
Comprehensive loss:(2,051)(2,603)(8,835)(633)(3,856)(2,437)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent558404,180(527)(975)(1,897)
Comprehensive loss, net of tax, attributable to parent:(1,492)(2,564)(4,655)(1,160)(4,831)(4,334)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: